Physician profile
Frederic J Levine
NPI 1043205867
$7,605.58
in general payments reported to CMS, 2019-2025
39 companies · $1,338 in 2025
The $1,338 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $499 · 2020: $601 · 2021: $1,381 · 2022: $1,036 · 2023: $1,421 · 2024: $1,329 · 2025: $1,338.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,963 · Education: $126.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,962.54 |
| Education | $125.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $955.72 | 2019-2025 | Xtandi, Myrbetriq |
| Sumitomo Pharma America, INC. | $788.50 | 2023-2025 | Orgovyx, Gemtesa |
| Dendreon Pharmaceuticals LLC | $704.74 | 2020-2025 | Provenge |
| Abbvie INC. | $570.80 | 2019-2025 | |
| Tolmar, INC. | $465.89 | 2023-2025 | Eligard, Jatenzo |
| Bayer Healthcare Pharmaceuticals INC. | $428.31 | 2021-2025 | |
| C. R. Bard, INC. & Subsidiaries | $384.50 | 2022-2023 | Bard Urinary Drainage Bag |
| Janssen Biotech, INC. | $318.63 | 2021-2025 | Erleada |
| Endo Pharmaceuticals INC. | $296.55 | 2019-2024 | Xiaflex, Aveed |
| Rochester Medical Corporation | $278.93 | 2021-2022 | |
| Pfizer INC. | $266.03 | 2020-2025 | |
| Tolmar Pharmaceuticals, INC. | $224.31 | 2020-2022 | |
| Ferring Pharmaceuticals INC. | $164.74 | 2019-2025 | Adstiladrin |
| Teleflex LLC | $158.95 | 2021-2022 | |
| Boston Scientific Corporation | $151.48 | 2019-2022 |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Antares Pharma, INC. | $149.50 | 2019-2025 | Xyosted, Nocdurna, Tlando |
| Coloplast Corp | $137.32 | 2019-2024 | |
| Astrazeneca Pharmaceuticals Lp | $130.27 | 2020-2023 | Lynparza |
| Myovant Sciences INC. | $117.67 | 2021-2022 | |
| Urogen Pharma, INC. | $102.52 | 2020-2025 | |
| Merck Sharp & Dohme LLC | $70.13 | 2023-2024 | Keytruda, Lynparza |
| Blue Earth Diagnostics | $69.22 | 2022-2023 | |
| Allergan, INC. | $68.87 | 2019-2020 | |
| Axonics, INC. | $65.90 | 2021 | |
| Convatec INC. | $63.47 | 2021-2022 | |
| Progenics Pharmaceuticals, INC. | $58.50 | 2022-2023 | Pylarify |
| Endo USA, INC. | $47.76 | 2024-2025 | Xiaflex |
| Dentsply Ih INC. | $47.35 | 2020 | |
| Sun Pharmaceutical Industries INC. | $46.98 | 2022 | |
| Foundation Medicine, INC. | $41.57 | 2022-2023 | |
| Neotract INC. | $36.59 | 2019 | |
| Metuchen Pharmaceuticals | $33.32 | 2019-2020 | |
| Urovant Sciences INC | $31.79 | 2022 | |
| Calyxo, INC. | $24.75 | 2025 | Cvac Aspiration System |
| Accord Healthcare, INC. | $23.47 | 2022 | |
| Novartis Pharmaceuticals Corporation | $23.05 | 2024 | |
| Halozyme INC | $20.14 | 2023 | |
| Telix Pharmaceuticals | $20.13 | 2024 | Illuccix |
| Laborie Medical Technologies Corp. | $17.23 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frederic Levine listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.